{
  "trial_id": "NCT03688555",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, nasal polyp score, systolic blood pressure, diastolic blood pressure, pulse rate, presence of nasal blockade/obstruction, presence of nasal discharge, presence of reduction or loss of smell, renal function (estimated glomerular filtration rate), Sino-Nasal Outcome Test (SNOT-22) score, forced expiratory volume in one second (FEV1), use of intranasal corticosteroids (INCS), use of oral corticosteroids (OCS), history of nasal surgery, presence of co-morbid asthma, presence of autoimmune disease, liver function tests (alanine aminotransferase, bilirubin).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Body Mass Index (BMI)"
      ],
      "remaining_candidate_features": [
        "nasal polyp score",
        "systolic blood pressure",
        "diastolic blood pressure",
        "pulse rate",
        "presence of nasal blockade/obstruction",
        "presence of nasal discharge",
        "presence of reduction or loss of smell",
        "renal function (estimated glomerular filtration rate)",
        "Sino-Nasal Outcome Test (SNOT-22) score",
        "forced expiratory volume in one second (FEV1)",
        "use of intranasal corticosteroids (INCS)",
        "use of oral corticosteroids (OCS)",
        "history of nasal surgery",
        "presence of co-morbid asthma",
        "presence of autoimmune disease",
        "liver function tests (alanine aminotransferase, bilirubin)"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline Nasal Polyp Score, Systolic Blood Pressure, Diastolic Blood Pressure, Pulse Rate, Presence of Nasal Blockade/Obstruction, Presence of Nasal Discharge, Presence of Reduction or Loss of Smell,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Body Mass Index (BMI)"
      ],
      "remaining_candidate_features": [
        "Baseline Nasal Polyp Score",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Pulse Rate",
        "Presence of Nasal Blockade/Obstruction",
        "Presence of Nasal Discharge",
        "Presence of Reduction or Loss of Smell"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Nasal Polyp Score, SNOT-22 Score, Nasal Blockage/Obstruction, Nasal Discharge, Reduction or Loss of Smell.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Body Mass Index (BMI)",
          "Body Mass Index"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Nasal Polyp Score",
        "SNOT-22 Score",
        "Nasal Blockage/Obstruction",
        "Nasal Discharge",
        "Reduction or Loss of Smell."
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), systolic blood pressure, diastolic blood pressure, pulse rate, nasal polyp score (NPS), Sino-Nasal Outcome Test (SNOT-22) score, forced expiratory volume in one second (FEV1), presence of symptoms (nasal blockade/obstruction, nasal discharge, reduction or loss of smell), prior intranasal corticosteroids (INCS) treatment, duration of bilateral nasal polyposis, history of asthma, history of autoimmune disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Body Mass Index (BMI)",
          "body mass index (BMI)"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "systolic blood pressure",
        "diastolic blood pressure",
        "pulse rate",
        "nasal polyp score (NPS)",
        "Sino-Nasal Outcome Test (SNOT-22) score",
        "forced expiratory volume in one second (FEV1)",
        "presence of symptoms (nasal blockade/obstruction, nasal discharge, reduction or loss of smell)",
        "prior intranasal corticosteroids (INCS) treatment",
        "duration of bilateral nasal polyposis",
        "history of asthma",
        "history of autoimmune disease."
      ]
    }
  }
}